Your browser doesn't support javascript.
loading
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.
Greaney, Allison J; Eguia, Rachel T; Starr, Tyler N; Khan, Khadija; Franko, Nicholas; Logue, Jennifer K; Lord, Sandra M; Speake, Cate; Chu, Helen Y; Sigal, Alex; Bloom, Jesse D.
Afiliación
  • Greaney AJ; Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center; Seattle, WA, USA.
  • Eguia RT; Department of Genome Sciences & Medical Scientist Training Program, University of Washington; Seattle, WA, USA.
  • Starr TN; Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center; Seattle, WA, USA.
  • Khan K; Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center; Seattle, WA, USA.
  • Franko N; Howard Hughes Medical Institute; Chevy Chase, MD, USA.
  • Logue JK; Africa Health Research Institute, Durban, South Africa.
  • Lord SM; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Speake C; Division of Allergy and Infectious Diseases, University of Washington; Seattle, WA, USA.
  • Chu HY; Division of Allergy and Infectious Diseases, University of Washington; Seattle, WA, USA.
  • Sigal A; Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason.
  • Bloom JD; Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason.
bioRxiv ; 2022 Mar 14.
Article en En | MEDLINE | ID: mdl-35313588
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2022 Tipo del documento: Article